← Back to Search

OCS Liver Transplant Recipients for Liver Transplant (OLP-II Trial)

N/A
Recruiting
Research Sponsored by TransMedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All liver transplant recipients who are transplanted with an OCS-perfused donor liver are eligible for the Registry
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year
Awards & highlights

OLP-II Trial Summary

OLP-II Registry is a sponsor-initiated, multi-center, observational, post-approval registry.

OLP-II Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

OLP-II Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Survival

OLP-II Trial Design

1Treatment groups
Experimental Treatment
Group I: OCS Liver Transplant RecipientsExperimental Treatment1 Intervention
All liver transplant recipients who are transplanted with an OCS-perfused donor liver are eligible for the Registry. Up to 10,000 subjects will be enrolled.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OCS Liver
2016
N/A
~330

Find a Location

Who is running the clinical trial?

TransMedicsLead Sponsor
22 Previous Clinical Trials
8,571 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6667 spots leftby Sep 2029